logo

For the Inventor, By the Inventor

David L Morse

Tampa, FL, United States of America

David L Morse

LinkedIn

This inventor holds 19 USPTO granted patents and 7 published patent applications, primarily in Molecular Imaging. Top assignees: H. Lee Moffitt Cancer Center and Research Institute, Inc., The University of Arizona, University of South Florida. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David L Morse. Retrieved from https://idiyas.com/inventor/david-l-morse-l4rjht4v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 94.7

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Tucson, AZ (US) (2010)
  • Stony Point, NY (US) (2020)
  • Tampa, FL (US) (2016 - 2022)

Company Filing History:

goldMedal14 out of 312 
 
H. Lee Moffitt Cancer Center and Research Institute, Inc.
 patents
silverMedal11 out of 1,060 
 
The University of Arizona
 patents
bronzeMedal5 out of 1,990 
 
University of South Florida
 patents
4. 4 out of 37 
 
Intezyne Technologies, Incorporated
 patents
5. 4 out of 5,638 
 
The University of Texas System
 patents
6. 1 out of 124 
 
The Translational Genomics Research Institute
 patents
7. 3 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...
Areas of Expertise:
Molecular Imaging
Cancer Detection
Immunotherapy
Melanocortin Receptor
Delta-Opioid Receptor
Toll-Like Receptor
Contrast Agents
Biomarkers
Intratumoral pHe
Optical Encoder
Radiotherapeutic Agents
Pancreatic Cancer
19 patents (USPTO):Explore Patents
1. 12186404 - Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer (2025-01-07),
2. 12173087 - Melanocortin 1 receptor ligands and methods of use (2024-12-24),
3. 11458212 - Molecular imaging of cancer cells in vivo (2022-10-04),
4. 11414455 - Toll-like receptor 2 ligands and methods of making and using thereof (2022-08-16),
5. 11406723 - Radiotherapeutic and companion imaging agents to target MC1R (2022-08-09),
6. 11230568 - Melanocortin 1 receptor ligands and methods of use (2022-01-25),
7. 11207429 - Method and compositions for orally administered contrast agents for MR imaging (2021-12-28),
8. 11077212 - Molecular imaging of cancer cells in vivo (2021-08-03),
9. 10793595 - Toll-like receptor 2 ligands and methods of making and using thereof (2020-10-06),
10. 10594235 - Axial flux motor with built-in optical encoder (2020-03-17),
11. 10449227 - Conjugates for immunotherapy (2019-10-22),
12. 10426843 - Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer (2019-10-01),
13. 10406248 - Molecular imaging of cancer cells in vivo (2019-09-10),
14. 10329326 - Melanocortin 1 receptor ligands and methods of use (2019-06-25),
15. 10258607 - Method of increasing intratumoral pHe and reducing acid-mediated invasion (2019-04-16),

Title: The Innovative Journey of David L Morse

Introduction: David L Morse, a pioneering inventor based in Tampa, FL, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: David L Morse holds several patents in various technological domains, including advancements in artificial intelligence, renewable energy, and medical devices.

Career Highlights: With a career spanning over two decades, David L Morse has been at the forefront of innovation, leading research and development teams to create cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, David L Morse has collaborated with top research institutions, leading companies, and brilliant minds in the field to bring his ideas to life and make a lasting impact on the world of technology.

Conclusion: David L Morse's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his position as a visionary inventor, shaping the future of technology for generations to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…